77,044,708 Ordinary Shares of Clarity Pharmaceuticals Ltd are subject to a Lock-Up Agreement Ending on 25-AUG-2023. These Ordinary Shares will be under lockup for 732 days starting from 23-AUG-2021 to 25-AUG-2023.

Details:
Board of Directors and their related parties escrowed 77,044,708 fully paid ordinary shares classified by ASX as restricted securities and to be held in escrow until 25 August 2023, being 24 months from the date of commencement of Official Quotation.

6,265,585 fully paid ordinary shares classified by ASX as restricted securities and to be held in escrow until 29 September 2021, being 12 months from the date of issue.

6,642,100 fully paid ordinary shares classified by ASX as restricted securities and to be held in escrow until 15 December 2021, being 12 months from the date of issue.

728,572 fully paid ordinary shares classified by ASX as restricted securities and to be held in escrow until 29 June 2022, being 12 months from the date of issue.

2,400,000 options exercisable at $0.22 on or before 1 July 2023, classified by ASX as restricted securities and to be held in escrow until 25 August 2023, being 24 months from the date of commencement of Official Quotation.

3,000,000 options exercisable at $0.61 on or before 1 December 2024, classified by ASX as restricted securities and to be held in escrow until 25 August 2023, being 24 months from the date of commencement of Official Quotation.

3,400,000 options exercisable at $0.83 on or before 18 December 2024, classified by ASX as restricted securities and to be held in escrow until 25 August 2023, being 24 months from the date of commencement of Official Quotation.

2,500,000 options exercisable at $0.94 on or before 10 May 2026, classified by ASX as restricted securities and to be held in escrow until 25 August 2023, being 24 months from the date of commencement of Official Quotation.

918,220 options exercisable at $1.13 on or before 15 December 2023, classified by ASX as restricted securities and to be held in escrow until 25 August 2023, being 24 months from the date of commencement of Official Quotation.

25,543,912 options exercisable at $1.75 on or before 25 February 2022, classified by ASX as restricted securities and to be held in escrow until 1 July 2022, being 12 months from the date of issue.